In today’s briefing:
- Delhivery IPO: Offering Details & Index Inclusion Timeline
- Yamada Denki – GINORMOUS Buyback To Dramatically Boost EPS and ROE
- Shareholder Vote On 6 June For Virtus-Backed Offer From CapVest
- Hitachi Metals – Nice Rebound Reduces Forward Reward/Risk Ratio
Delhivery IPO: Offering Details & Index Inclusion Timeline
- Delhivery (1058656D IN) is looking at raising INR 52,350m (US$685m) in its IPO by selling up to 113.3m shares at a range of INR 462-487/share.
- At the mid point of the IPO range, Delhivery (1058656D IN) will be valued at INR 344.8bn (US$4.5bn) while the free float market cap will be much lower.
- Delhivery (1058656D IN) could get entry to the FTSE All-World Index at the December QIR, while inclusion in the MSCI India Index could take place at the May 2023 SAIR.
Yamada Denki – GINORMOUS Buyback To Dramatically Boost EPS and ROE
- Yamada Denki (9831 JP) reported earnings (Revs -7.6% (slight beat), OP -28.6% (slight miss), NP -2.4% (slight miss)), and slightly upbeat forecasts to Mar-2023 (Revs +4.6%, OP +12.5%, NP +2.9%)
- They also announced an unchanged dividend at ¥18/share, and a VERY BIG BUYBACK. This is one of the largest, most aggressive, on-market buyback programs I have ever seen.
- Previous buybacks have been duds. Yamada Denki is not playing around this time. This time it will be a buy.
Shareholder Vote On 6 June For Virtus-Backed Offer From CapVest
- CapVest has a concurrent Scheme for Virtus Health (VRT AU) at $8.15/share and an off-market Takeover bid at $8.10/share (conditional on, among other things, the Scheme not proceeding).
- The Transaction Booklet is now out. The Scheme Meeting will be held on the 6 June. If not approved, the Takeover closes on the 5 July – unless extended.
- The Virtus Directors unanimously recommend shareholders vote in favour of the Scheme; and accept the CapVest Takeover should the Scheme not be approved.
Hitachi Metals – Nice Rebound Reduces Forward Reward/Risk Ratio
- Last week Hitachi Metals (5486 JP) reported decent earnings and strong forecasts against what is probably significantly stale consensus expectations.
- “The Consortium is not aware of any significant problems with procedures/responses under the Competition Act and will continue to strive to complete these procedures and responses as early as possible.”
- That caused a jump, but that is the same language used in the 30 Nov 2021 release. Yes, I think this gets done, but Reward/Risk is smaller now.
Before it’s here, it’s on Smartkarma